1 - 25 of 74 results for author:"Sawada J." in Literature citations
Results Customize
› Repeat search in UniProtKB (176)
| Genetic polymorphisms of FCGR2A encoding Fcgamma receptor IIa in a Japanese population and functional analysis of the L273P variant. Tada M., Ishii-Watabe A., Maekawa K., Fukushima-Uesaka H., Kurose K., Suzuki T., Kaniwa N., Sawada J., Kawasaki N., Nakajima T.E. et al. Immunogenetics 64:869-877(2012) · Mapped (2) |
| Genetic variation and haplotype structures of the glutathione S-transferase genes GSTA1 and GSTA2 in Japanese colorectal cancer patients. Maekawa K., Hamaguchi T., Saito Y., Tatewaki N., Kurose K., Kaniwa N., Eguchi Nakajima T., Kato K., Yamada Y., Shimada Y. et al. Drug Metab. Pharmacokinet. 26:646-658(2011) · Mapped (6) |
| Genetic polymorphisms and haplotypes of por, encoding cytochrome p450 oxidoreductase, in a Japanese population. Saito Y., Yamamoto N., Katori N., Maekawa K., Fukushima-Uesaka H., Sugimoto D., Kurose K., Sai K., Kaniwa N., Sawada J. et al. Drug Metab. Pharmacokinet. 26:107-116(2011) · Mapped (9) |
| Genome-wide association study on overall survival of advanced non-small cell lung cancer patients treated with carboplatin and paclitaxel. Sato Y., Yamamoto N., Kunitoh H., Ohe Y., Minami H., Laird N.M., Katori N., Saito Y., Ohnami S., Sakamoto H. et al. J Thorac Oncol 6:132-138(2011) · Mapped (9) |
| Genetic polymorphisms of FCGRT encoding FcRn in a Japanese population and their functional analysis. Ishii-Watabe A., Saito Y., Suzuki T., Tada M., Ukaji M., Maekawa K., Kurose K., Kaniwa N., Sawada J., Kawasaki N. et al. Drug Metab. Pharmacokinet. 25:578-587(2010) · Mapped (2) |
| Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients. Sai K., Saito Y., Tatewaki N., Hosokawa M., Kaniwa N., Nishimaki-Mogami T., Naito M., Sawada J., Shirao K., Hamaguchi T. et al. Br J Clin Pharmacol 70:222-233(2010) · Mapped (15) |
| Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms. Sugiyama E., Kaniwa N., Kim S.R., Hasegawa R., Saito Y., Ueno H., Okusaka T., Ikeda M., Morizane C., Kondo S. et al. Clin Pharmacokinet 49:549-558(2010) · Mapped (12) |
| TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Aizawa H., Sawada J., Hideyama T., Yamashita T., Katayama T., Hasebe N., Kimura T., Yahara O., Kwak S. Acta Neuropathol. 120:75-84(2010) · Mapped (14) |
| Binding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradation. Okuhira K., Fitzgerald M.L., Tamehiro N., Ohoka N., Suzuki K., Sawada J., Naito M., Nishimaki-Mogami T. J. Biol. Chem. 285:16369-16377(2010) · Mapped (15) |
| Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients. Fukushima-Uesaka H., Saito Y., Maekawa K., Kurose K., Sugiyama E., Katori N., Kaniwa N., Hasegawa R., Hamaguchi T., Eguchi-Nakajima T. et al. Drug Metab. Pharmacokinet. 24:565-574(2009) · Mapped (13) |
| Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene. Sugiyama E., Lee S.J., Lee S.S., Kim W.Y., Kim S.R., Tohkin M., Hasegawa R., Okuda H., Kawamoto M., Kamatani N. et al. Drug Metab. Pharmacokinet. 24:553-556(2009) · Mapped (3) |
| Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients. Sai K., Saito Y., Maekawa K., Kim S.R., Kaniwa N., Nishimaki-Mogami T., Sawada J., Shirao K., Hamaguchi T., Yamamoto N. et al. Cancer Chemother. Pharmacol. 66:95-105(2010) · Mapped (36) |
| Genetic variations of the ABC transporter gene ABCB11 encoding the human bile salt export pump (BSEP) in a Japanese population. Kim S.R., Saito Y., Itoda M., Maekawa K., Kawamoto M., Kamatani N., Ozawa S., Sawada J. Drug Metab. Pharmacokinet. 24:277-281(2009) · Mapped (5) |
| Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients. Ueno H., Kaniwa N., Okusaka T., Ikeda M., Morizane C., Kondo S., Sugiyama E., Kim S.R., Hasegawa R., Saito Y. et al. Br. J. Cancer 100:870-873(2009) · Mapped (3) |
| Genetic variations and haplotype structures of the glutathione S-transferase genes, GSTT1 and GSTM1, in a Japanese patient population. Tatewaki N., Maekawa K., Katori N., Kurose K., Kaniwa N., Yamamoto N., Kunitoh H., Ohe Y., Nokihara H., Sekine I. et al. Drug Metab. Pharmacokinet. 24:118-126(2009) · Mapped (11) |
| HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Kaniwa N., Saito Y., Aihara M., Matsunaga K., Tohkin M., Kurose K., Sawada J., Furuya H., Takahashi Y., Muramatsu M. et al. Pharmacogenomics 9:1617-1622(2008) · Mapped (992) |
| Close association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 haplotype and its apparent influence on 7-ethyl-10-hydroxycamptothecin (SN-38) glucuronidation in Japanese. Saito Y., Sai K., Maekawa K., Kaniwa N., Shirao K., Hamaguchi T., Yamamoto N., Kunitoh H., Ohe Y., Yamada Y. et al. Drug Metab. Dispos. 37:272-276(2009) · Mapped (22) |
| Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK). Kim S.R., Saito Y., Maekawa K., Sugiyama E., Kaniwa N., Ueno H., Okusaka T., Ikeda M., Morizane C., Yamamoto N. et al. Drug Metab. Pharmacokinet. 23:379-384(2008) · Mapped (3) |
| Genetic variations of CYP2C9 in 724 Japanese individuals and their impact on the antihypertensive effects of losartan. Yin T., Maekawa K., Kamide K., Saito Y., Hanada H., Miyashita K., Kokubo Y., Akaiwa Y., Otsubo R., Nagatsuka K. et al. Hypertens. Res. 31:1549-1557(2008) · Mapped (7) |
| Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population. Sai K., Saito Y., Itoda M., Fukushima-Uesaka H., Nishimaki-Mogami T., Ozawa S., Maekawa K., Kurose K., Kaniwa N., Kawamoto M. et al. Drug Metab. Pharmacokinet. 23:139-147(2008) · Mapped (2) |
| Hypoxia induces expression of a GPI-anchorless splice variant of the prion protein. Kikuchi Y., Kakeya T., Nakajima O., Sakai A., Ikeda K., Yamaguchi N., Yamazaki T., Tanamoto K., Matsuda H., Sawada J. et al. |
| [Irinotecan pharmacogenetics in Japanese cancer patients: roles of UGT1A1*6 and *28]. Sai K., Sawada J., Minami H. Yakugaku Zasshi 128:575-584(2008) · Mapped (15) |
| Influence of CYP2C19*18 and CYP2C19*19 alleles on omeprazole 5-hydroxylation: in vitro functional analysis of recombinant enzymes expressed in Saccharomyces cerevisiae. Hanioka N., Tsuneto Y., Saito Y., Maekawa K., Sawada J., Narimatsu S. Basic Clin. Pharmacol. Toxicol. 102:388-393(2008) · Mapped (3) |
| Genetic variations of VDR/NR1I1 encoding vitamin D receptor in a Japanese population. Ukaji M., Saito Y., Fukushima-Uesaka H., Maekawa K., Katori N., Kaniwa N., Yoshida T., Nokihara H., Sekine I., Kunitoh H. et al. Drug Metab. Pharmacokinet. 22:462-467(2007) · Mapped (6) |
| Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15. Kim S.R., Saito Y., Sai K., Kurose K., Maekawa K., Kaniwa N., Ozawa S., Kamatani N., Shirao K., Yamamoto N. et al. Drug Metab. Pharmacokinet. 22:456-461(2007) · Mapped (5) |